These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10898050)

  • 1. Continuous ambulatory peritoneal dialysis is responsible for an increase in plasma norepinephrine.
    Vlachojannis JG; Tsakas S; Alexandri S; Petropoulou C; Goumenos DS
    Perit Dial Int; 2000; 20(3):322-7. PubMed ID: 10898050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin-1 in continuous ambulatory peritoneal dialysis and hemodialysis patients: a preliminary study.
    Lightfoot BO; Caruana RJ
    Perit Dial Int; 1993; 13(1):55-8. PubMed ID: 8443279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The red blood cell deformability in patients suffering from end stage renal failure on hemodialysis or continuous ambulatory peritoneal dialysis.
    Sotirakopoulos N; Tsitsios T; Stambolidou M; Athanasiou G; Peiou M; Kokkinou V; Mavromatidis K
    Ren Fail; 2004 Mar; 26(2):179-83. PubMed ID: 15287203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of human atrial natriuretic factor in patients treated by hemodialysis and continuous ambulatory peritoneal dialysis.
    Ando R; Matsuda O; Miyake S; Yoshiyama N
    Nephron; 1988; 50(3):225-8. PubMed ID: 2976122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of plasma amino acid concentrations in end-stage renal disease patients on hemodialysis and peritoneal dialysis.
    Kim DH; Yang DH; Hong SY
    Korean J Intern Med; 1998 Feb; 13(1):33-40. PubMed ID: 9538629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased endothelin-1 mRNA expression in peripheral blood monocytes of dialysis patients.
    Ebihara I; Nakamura T; Takahashi T; Tomino Y; Shimada N; Koide H
    Perit Dial Int; 1997; 17(6):595-601. PubMed ID: 9655160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis?
    Cueto-Manzano AM; Rojas-Campos E; Martínez-Ramírez HR; Valera-González I; Medina M; Monteón F; Ruiz N; Becerra M; Palomeque MA; Cortés-Sanabria L
    Perit Dial Int; 2006; 26(3):341-8. PubMed ID: 16722027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
    Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
    Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma interleukin-18 levels in chronic renal failure and continuous ambulatory peritoneal dialysis.
    Chiang CK; Hsu SP; Pai MF; Peng YS; Ho TI; Liu SH; Hung KY; Tsai TJ; Hsieh BS
    Blood Purif; 2005; 23(2):144-8. PubMed ID: 15677863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients--Italian initiative on uremic hyperhomocysteinemia (IIUH).
    Perna AF; Ingrosso D; Molino D; Galletti P; Montini G; Zacchello G; Bellantuono R; Caringella A; Fede C; Chimenz R; De Santo NG
    J Nephrol; 2003; 16(4):516-21. PubMed ID: 14696753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of continuous ambulatory peritoneal dialysis and hemodialysis on serum pepsinogen concentrations in patients with chronic renal failure.
    Aydemir S; Borazan A; Acikgoz S; Ustundag Y; Yilmaz A
    Tohoku J Exp Med; 2005 Mar; 205(3):263-8. PubMed ID: 15718818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.
    Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P
    J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 gene expression in peripheral blood mononuclear cells from patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis.
    Takahashi T; Kubota M; Nakamura T; Ebihara I; Koide H
    Ren Fail; 2000 May; 22(3):345-54. PubMed ID: 10843245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
    Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC
    Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of brain natriuretic peptides in patients on continuous ambulatory peritoneal dialysis.
    Nakatani T; Naganuma T; Masuda C; Uchida J; Sugimura T; Sugimura K
    Int J Mol Med; 2002 Oct; 10(4):457-61. PubMed ID: 12239593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis.
    Chuang CK; Lin SP; Chen HH; Chen YC; Wang TJ; Shieh WH; Wu CJ
    Clin Chim Acta; 2006 Feb; 364(1-2):209-16. PubMed ID: 16087168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two different Kt/V methods in continuous ambulatory peritoneal dialysis patients.
    Sanlidag C; Cavdar C; Sifil A; Hastaoglu S; Uretmen P; Camsari T
    Perit Dial Int; 1999; 19 Suppl 2():S514-6. PubMed ID: 10406576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes.
    Satirapoj B; Supasyndh O; Phantana-Angkul P; Ruangkanchanasetr P; Nata N; Chaiprasert A; Kanjanakul I; Choovichian P
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S87-93. PubMed ID: 22043573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.